| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
3,329 |
1,937 |
$49K |
| 87428 |
|
737 |
535 |
$43K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
849 |
613 |
$38K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
2,760 |
1,238 |
$21K |
| 95816 |
|
54 |
34 |
$9K |
| 98960 |
|
79 |
13 |
$8K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
22 |
14 |
$3K |
| 96132 |
|
38 |
34 |
$3K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
36 |
26 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
33 |
27 |
$1K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
15 |
12 |
$787.38 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
13 |
13 |
$750.00 |
| 96136 |
|
17 |
17 |
$612.45 |
| 96137 |
|
17 |
17 |
$567.15 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
14 |
14 |
$250.00 |
| 99070 |
|
20 |
17 |
$232.50 |
| 93040 |
|
17 |
17 |
$170.10 |
| 95905 |
|
21 |
17 |
$0.00 |
| 95957 |
|
21 |
17 |
$0.00 |